This study evaluated the diagnostic effectiveness of the Apolipoprotein A2-isoform (APOA2-i) Index for early detection of pancreatic cancer in combination with the conventional tumor marker CA 19-9. Here, APOA2 is linked to pancreatic neoplasm.